Penn Medicine Provider
Pulmonary Medicine
Thuonghien Vu Tran, DO
4.9
(108)
Accepting new patients
Sees patients age 18 and up
Harron Lung Center Washington Square
Schedule onlineCall 215-829-5027

About me

  • Assistant Professor of Clinical Medicine (Pulmonary, Allergy and Critical Care)

Education and training

  • Medical School: Philadelphia College of Osteopathic Medicine
  • Residency: Indiana University Hospital
  • Fellowship: University of Iowa Hospitals and Clinics

What my patients think about me

Average Rating
4.9

108 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
understood me
April 2025
5.0
5.0
appreciate him being my doctor.
April 2025
5.0
5.0
willing to work with me either in person or televisit
March 2025
5.0
5.0
simply a very well educated in with lungs issues. never late and always is informative

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Tran is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Tran, T Prevalence of Abnormal Spirometry in Ever smokers with No Known Obstructive Lung Disease , American Thoracic Society: 2022

Tran T., Desai H., Carlos W.G. What broke my heart? , CHEST, San Antonio, TX: 2018

Tran T., Crowley E., Hage C. Rules are meant to be broken: successful lung transplantation in a patient with cystic fibrosis and HIV. , CHEST, San Antonio, TX: 2018

Tran T., Crowley E., Khare S., Imel E. Impact of Cystic Fibrosis Related Diabetes (CFRD) on Bone Density. , North American Cystic Fibrosis Conference. Denver CO: 2018

Tran T., Nabil A., Sheski F. First Impressions Matter: Diffuse Alveolar Hemorrhage After One Dose of Gemcitabine. , American Thoracic Society. San Diego, CA: 2018

Tran T.H., El Baz R., Cuconati A., Arthos J., Jain P., Khan Z.K. A Novel High-Throughput Screening Assay to Identify Inhibitors of HIV-1 gp120 Protein Interaction with DC-SIGN. , Journal of Antivirals and Antiretrovirals, 3: 2011,49-54